Patients with proliferative diabetic retinopathy requiring panretinal photocoagulation (PRP) treatment
Conditions
Interventions
None listed
Sponsors
Kyorin University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients scheduled to undergo vitreous surgery for proliferative diabetic retinopathy during the study period, who have not received PRP or require additional PRP. 2. Patients expected to receive 2,000 to 4,000 laser shots during PRP. 3. Patients scheduled to undergo PRP from the vascular arcade to the peripheral retina (near the ora serrata). 4. Patients aged 20 years or older at the time of consent. 5. Patients who have provided written informed consent of their own free will to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Patients with retinal diseases other than diabetic retinopathy, such as retinal vein occlusion or uveitis 2. Patients with neovascular glaucoma 3. Patients using steroids or other anti-inflammatory drugs 4. Patients whose random blood glucose level is 350 mg/dL or higher, or whose HbA1c is greater than 10.0. 5. Patients with systemic complications that make imaging difficult 6. Patients deemed inappropriate for inclusion by the investigator 7. Patients who have expressed unwillingness to participate in this study, or whose legally authorized representatives have expressed such unwillingness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of total laser application per laser spot applied (sec/1 spot)(During surgery) | — |
Countries
Japan
Contacts
Public ContactMakoto Inoue
Kyorin University Hospital (Kyorin Eye Center) Department of Ophthalmology
Outcome results
None listed